Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group

Author： Smith H.O.   Blessing J.A.   Vaccarello L.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.84, Iss.1, 2002-01, pp. : 140-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Blessing J.A.   Ball H.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 346-349

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Thigpen T.   Blessing J.A.   Yordan E.   Valea F.   Vaccarello L.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 120-122

Academic Press

Access to resources Recommend Favorite

Phase II Evaluation of Oral Trimetrexate in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

By Fowler J.M.   Blessing J.A.   Burger R.A.   Malfetano J.H.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 311-314

Academic Press

Access to resources Recommend Favorite

Phase II Study of Mitomycin, Doxorubicin, and Cisplatin in the Treatment of Advanced Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study

By Edmonson J.H.   Blessing J.A.   Cosin J.A.   Miller D.S.   Cohn D.E.   Rotmensch J.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 507-510

Academic Press

Access to resources Recommend Favorite

Prolonged Oral Etoposide in Recurrent or Advanced Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Soper J.T.   Barter J.F.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 267-271

Elsevier

Access to resources Recommend Favorite